Nektar Therapeutics
Simbolo: 0UNL.L
LSE
1.65
USDPrezzo di mercato oggi
-1.1419
Rapporto P/E
0.0069
Rapporto PEG
302.98M
Capitalizzazione MRK
- 0.00%
Rendimento DIV
Nektar Therapeutics (0UNL-L) Bilanci finanziari
Stato patrimoniale
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 303.6 | 505 | 734 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 283.5 | 438.1 | 719.7 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 2.3 | 6 | 23.9 | ||||||||||||
balance-sheet.row.inventory | 0 | 16.1 | 19.2 | 15.8 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 8.7 | 15.8 | 21.9 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 330.7 | 546 | 795.6 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 36.9 | 85.9 | 177.5 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 76.5 | 76.5 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 76.5 | 76.5 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 25.8 | 0 | 64.8 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 4.6 | 2.2 | 2.7 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 67.3 | 164.6 | 321.6 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 398 | 710.6 | 1117.2 | ||||||||||||
balance-sheet.row.account-payables | 0 | 9.8 | 13 | 9.7 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 19.3 | 18.7 | 17.4 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 112.6 | 126.5 | 148.1 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 22.2 | 36.6 | 58 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 215.8 | 275.8 | 352.5 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 98.5 | 112.8 | 125.7 | ||||||||||||
balance-sheet.row.total-liab | 0 | 267 | 344 | 437.7 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | -3477.2 | -3201.2 | -2833 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0.1 | -6.9 | -4.2 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 3608.1 | 3574.7 | 3516.6 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 131 | 366.6 | 679.5 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 398 | 710.6 | 1117.2 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 0 | 131 | 366.6 | 679.5 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 309.3 | 438.1 | 784.5 | ||||||||||||
balance-sheet.row.total-debt | 0 | 230.4 | 258 | 291.3 | ||||||||||||
balance-sheet.row.net-debt | 0 | 210.2 | 191.1 | 277 |
Rendiconto finanziario
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -276.1 | -368.2 | -523.8 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 7.8 | 12.2 | 13 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -0.1 | 2.7 | -106.6 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | -13 | 57.3 | 94.7 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -19.8 | 0.5 | -23.1 | ||||||||||||
cash-flows.row.account-receivables | 0 | 4.8 | 16.5 | 12.4 | ||||||||||||
cash-flows.row.inventory | 0 | 0.7 | -3.4 | -0.5 | ||||||||||||
cash-flows.row.account-payables | 0 | -2.9 | 3.1 | -11.7 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -22.4 | -15.7 | -23.3 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 108.6 | -8.5 | 133.1 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.9 | -5.7 | -15 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.2 | 13.2 | -217.8 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | -511.7 | -467.9 | -960.7 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 650.9 | 826.2 | 1178.5 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 217.8 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 139.6 | 365.8 | 202.8 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0.8 | 33.2 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 0.8 | 3 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 1.5 | 36.2 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 6.3 | -0.3 | -0.1 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -46.7 | 52.5 | -175.1 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 20.2 | 66.8 | 14.3 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 66.8 | 14.3 | 189.3 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | -192.6 | -304 | -412.7 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -0.9 | -5.7 | -15 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | -193.5 | -309.7 | -427.6 |
Riga del conto economico
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 90.1 | 92.1 | 101.9 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 36.6 | 29.1 | 34.7 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 53.5 | 62.9 | 67.2 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 190.9 | 303.2 | 513.3 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 227.5 | 332.3 | 548 | ||||||||||||
income-statement-row.row.interest-income | 0 | 19 | 22.2 | 44.7 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 25.3 | 28.9 | 47.3 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -138.8 | -124.7 | -77.2 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -138.8 | -124.7 | -77.2 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 25.3 | 28.9 | 47.3 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 7.8 | 12.2 | 13 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | -137.4 | -240.2 | -446.1 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | -276.3 | -365 | -523.3 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | -0.2 | 3.2 | 0.6 | ||||||||||||
income-statement-row.row.net-income | 0 | -276.1 | -368.2 | -523.8 |
Domande frequenti
Che cos'è Nektar Therapeutics (0UNL.L) totale attivo?
Nektar Therapeutics (0UNL.L) il totale delle attività è 398033000.000.
Qual è il fatturato annuo dell'impresa?
Il fatturato annuo è N/A.
Qual è il margine di profitto dell'azienda?
Il margine di profitto dell'azienda è 0.625.
Qual è il flusso di cassa libero dell'azienda?
Il flusso di cassa libero è -1.013.
Qual è il margine di profitto netto dell'impresa?
Il margine di profitto netto è -3.063.
Qual è il fatturato totale dell'azienda?
Le entrate totali sono -1.500.
Che cos'è il Nektar Therapeutics (0UNL.L) utile netto (reddito netto)?
L'utile netto (reddito netto) è -276056000.000.
Qual è il debito totale dell'azienda?
Il debito totale è 230401000.000.
Qual è il numero di spese operative?
Le spese operative sono 190903000.000.
Qual è la cifra della liquidità aziendale?
La liquidità aziendale è 0.000.